{"id":44553,"date":"2012-05-10T13:17:33","date_gmt":"2012-05-10T13:17:33","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/ncku-student-wins-prestigious-award-for-anti-cancer-research.php"},"modified":"2012-05-10T13:17:33","modified_gmt":"2012-05-10T13:17:33","slug":"ncku-student-wins-prestigious-award-for-anti-cancer-research","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/ncku-student-wins-prestigious-award-for-anti-cancer-research.php","title":{"rendered":"NCKU Student Wins Prestigious Award for Anti-Cancer Research"},"content":{"rendered":"<p><p>    TAINAN, Taiwan--(BUSINESS WIRE)--  <\/p>\n<p>    Wan-Pei Su, a graduate student of Molecular Medicine at    National Cheng Kung University (NCKU), southern Taiwan, has received a    Graduate\/Postdoctoral Travel Award from the American Society    for Biochemistry and Molecular Biology (ASBMB) to attend    the annual conference on Experimental Biology (EB) in San Diego    in April 2012.  <\/p>\n<p>    NCKU President Hwung-Hweng Hwung congratulated Su and her    advisor, Dr. Nan-Shan Chang, director of NCKU Institute of Molecular    Medicine, for winning international recognition. It is    expected that the efforts put into the research will benefit    the future clinical application, said Hwung.  <\/p>\n<p>    Prof. Chang has been devoted to the discovery and development    of the tumor suppressor WW domain-containing oxidoreductase    (designated WWOX, FOR or WOX1). Zfra is one of the proteins    which interact with WOX1. Su has carried on Changs research    findings to anti-cancer mechanism.  <\/p>\n<p>    Su is awarded for her research paper titled Self-polymerizing    Zfra peptides elicit immune response for targeting cancer    where the function of Zfra in anti-cancer therapy is    investigated.  <\/p>\n<p>    Zfra was first cloned by Dr. Changs group at the Guthrie    Research Institute, Sayre, PA, USA in 2005, according to Su,    and the role of Zfra in tumor necrosis factor signal pathway    has aroused attention since then.  <\/p>\n<p>    The most remarkable function of Zfra is its prevention of    growth of skin cancer basal cell carcinoma, melanoma, prostate    cancer, breast cancer and so on. It is foreseeable that Zfra    can be used as a vaccine against all kinds of cancers, said    Su.  <\/p>\n<p>    Of all the 195 award recipients this year, mainly from North    America and only 13 from Asia, 2 awardees come from Taiwan.  <\/p>\n<p>    The ASBMB, founded in 1906 and now based in Maryland, is a    prestigious, nonprofit scientific and educational organization    with over 12,000 members. Many of them are highly regarded    scientists, including Nobel laureates. ASBMB manages the    publication of premier journals such as Journal of Biological    Chemistry, Molecular & Cellular Proteomics, and Journal of    Lipid Research.  <\/p>\n<\/p>\n<p>Read the original post:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/ncku-student-wins-prestigious-award-011900628.html;_ylt=A2KJjajgv6tP.UkAmNX_wgt.\" title=\"NCKU Student Wins Prestigious Award for Anti-Cancer Research\">NCKU Student Wins Prestigious Award for Anti-Cancer Research<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> TAINAN, Taiwan--(BUSINESS WIRE)-- Wan-Pei Su, a graduate student of Molecular Medicine at National Cheng Kung University (NCKU), southern Taiwan, has received a Graduate\/Postdoctoral Travel Award from the American Society for Biochemistry and Molecular Biology (ASBMB) to attend the annual conference on Experimental Biology (EB) in San Diego in April 2012. NCKU President Hwung-Hweng Hwung congratulated Su and her advisor, Dr. Nan-Shan Chang, director of NCKU Institute of Molecular Medicine, for winning international recognition <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/ncku-student-wins-prestigious-award-for-anti-cancer-research.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-44553","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/44553"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=44553"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/44553\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=44553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=44553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=44553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}